Why the study?
To test the feasibility of a randomized trial comparing home blood pressure monitoring paired with a remote lifestyle intervention versus home monitoring alone versus control in individuals with a hypertensive disorder of pregnancy postpartum.
Does home blood pressure monitoring paired with a remote lifestyle intervention improve weight, blood pressure, and self-efficacy in postpartum overweight and obese individuals with a hypertensive disorder of pregnancy?
Does home blood pressure monitoring paired with a remote lifestyle intervention improve weight, blood pressure, and self-efficacy in postpartum overweight and obese individuals with a hypertensive disorder of pregnancy?
A pilot trial demonstrated the feasibility of home blood pressure monitoring and lifestyle intervention in the first year postpartum for overweight/obese individuals with prior hypertensive disorders of pregnancy, though it did not improve weight or self-efficacy.
Answers are grounded in this paper and cite their sources.
Pilot RCT confirms high retention but no weight or self-efficacy benefit; larger trials needed to test efficacy on postpartum hypertension.
OBJECTIVE: To test the feasibility of a randomised trial of home blood pressure monitoring paired with a remote lifestyle intervention (Heart Health 4 New Moms) versus home blood pressure monitoring alone versus control in individuals with a hypertensive disorder of pregnancy in the first year postpartum. DESIGN: Single-blinded three-arm randomised clinical trial. SETTING: Two tertiary care hospitals and a community organisation. POPULATION: Postpartum overweight and obese individuals with a hypertensive disorder of pregnancy and without pre-pregnancy hypertension or diabetes. METHODS: We assessed the feasibility of recruitment and retention of 150 participants to study completion at 1-year postpartum with randomisation 1:1:1 into each arm. Secondary aims were to test effects of the interventions on weight, blood pressure and self-efficacy. In total, 129 (87%) participants completed the 1-year postpartum study visit. Overall, 22% of participants developed stage 2 hypertension (≥140/90 mmHg or on anti-hypertensive medications) by 1 year postpartum. There were no differences in weight or self-efficacy across the study arms. CONCLUSION: In this pilot, randomised trial, we demonstrate feasibility of HBPM paired with a lifestyle intervention in the first year postpartum. We detected high rates of ongoing hypertension, emphasising the need for the development of effective interventions in this population.
No takes yet. Share an insight, caveat, or question.
Hauspurg et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: